Abstract
Pharmacological mobilization of hematopoietic stem progenitor cells (HSPCs) from bone marrow (BM) into peripheral blood (PB) is a result of mobilizing agent-induced “sterile inflammation” in the BM microenvironment due to complement cascade (ComC) activation. Here we provide evidence that ATP, as an extracellular nucleotide secreted in a pannexin-1-dependent manner from BM cells, triggers activation of the ComC and initiates the mobilization process. This process is augmented in a P2X7 receptor-dependent manner, and P2X7-KO mice are poor mobilizers. Furthermore, after its release into the extracellular space, ATP is processed by ectonucleotidases: CD39 converts ATP to AMP, and CD73 converts AMP to adenosine. We observed that CD73-deficient mice mobilize more HSPCs than do wild-type mice due to a decrease in adenosine concentration in the extracellular space, indicating a negative role for adenosine in the mobilization process. This finding has been confirmed by injecting mice with adenosine along with pro-mobilizing agents. In sum, we demonstrate for the first time that purinergic signaling involving ATP and its metabolite adenosine regulate the mobilization of HSPCs. Although ATP triggers and promotes this process, adenosine has an inhibitory effect. Thus, administration of ATP together with G-CSF or AMD3100 or inhibition of CD73 by small molecule antagonists may provide the basis for more efficient mobilization strategies.
Document Type
Article
Publication Date
3-30-2018
Digital Object Identifier (DOI)
https://doi.org/10.1038/s41375-018-0122-0
Funding Information
This work was supported by NIH grants 2R01 DK074720 and R01HL112788, the Stella and Henry Endowment, and the OPUS grant DEC-2016/23/B/NZ3/03157 to MZR. Dr. Abdel-Latif is supported by the University of Kentucky COBRE Early Career Program (P20 GM103527) and the NIH Grant R01 HL124266. MP was supported by NIH T32 HL134644 to MZR. HU’s is supported by grants from the São Paulo Research Foundation FAPESP (Project No. 2012/50880-4) and the National Council for Scientific and Technological Development (CNPq), Brazil.
Related Content
The online version of this article (https://doi.org/10.1038/s41375-018-0122-0) contains supplementary material, which is available to authorized users
Repository Citation
Adamiak, Mateusz; Bujko, Kamila; Cymer, Monika; Plonka, Monika; Glaser, Talita; Kucia, Magda; Ratajczak, Janina; Ulrich, Henning; Abdel-Latif, Ahmed; and Ratajczak, Mariusz Z., "Novel Evidence That Extracellular Nucleotides and Purinergic Signaling Induce Innate Immunity-Mediated Mobilization of Hematopoietic Stem/Progenitor Cells" (2018). Internal Medicine Faculty Publications. 148.
https://uknowledge.uky.edu/internalmedicine_facpub/148
Legends to Supplementary Figures
41375_2018_122_MOESM2_ESM.pptx (70 kB)
Supplementary Figure 1
41375_2018_122_MOESM3_ESM.pptx (54 kB)
Supplementary Figure 2
41375_2018_122_MOESM4_ESM.pptx (50 kB)
Supplementary Figure 3
41375_2018_122_MOESM5_ESM.pptx (68 kB)
Supplementary Figure 4
41375_2018_122_MOESM6_ESM.pptx (70 kB)
Supplementary Figure 5
Notes/Citation Information
Published in Leukemia, v. 32, issue 9, 1920-1931.
© The Author(s) 2018.
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.